Cargando…

One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention

Background There are no reports on the effectiveness of one-time use of the calcitonin gene-related peptide-related monoclonal antibodies (CGRP-mABs) evaluated at one and three months for migraine prevention. Here, we present the real-world data of one-time administration of CGRP-mABs, galcanezumab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsuki, Masahito, Kashiwagi, Kenta, Kawamura, Shin, Tachikawa, Senju, Koh, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951121/ https://www.ncbi.nlm.nih.gov/pubmed/36843788 http://dx.doi.org/10.7759/cureus.34180

Ejemplares similares

Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old
por: Katsuki, Masahito, et al.
Publicado: (2023)

Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases
por: Kashiwagi, Kenta, et al.
Publicado: (2023)

Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
por: Kawamura, Shin, et al.
Publicado: (2022)

Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023)

The Efficacy of Japanese Herbal Kampo Medicine as an Acute and Prophylactic Medication to Treat Chronic Daily Headache and Medication Overuse Headache:-Single Arm Retrospective Study
por: Katsuki, Masahito, et al.
Publicado: (2022)

Spontaneous Intracranial Hypotension Manifesting Orthostatic Headache Worsened by Playing the Saxophone and Treated by Japanese Herbal Kampo Medicine Goreisan
por: Katsuki, Masahito, et al.
Publicado: (2022)

Transient Global Amnesia Related to the Third Coronavirus Disease-19 (COVID-19) Vaccination
por: Katsuki, Masahito, et al.
Publicado: (2022)

Spontaneous Intracranial Hypotension Manifesting Orthostatic Headache Worsen by Playing the Trombone
por: Katsuki, Masahito, et al.
Publicado: (2022)

Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines
por: Katsuki, Masahito, et al.
Publicado: (2023)

Easily Created Prediction Model Using Automated Artificial Intelligence Framework (Prediction One, Sony Network Communications Inc., Tokyo, Japan) for Subarachnoid Hemorrhage Outcomes Treated by Coiling and Delayed Cerebral Ischemia
por: Katsuki, Masahito, et al.
Publicado: (2021)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Headache Education by E-Learning Through Social Networking Services (Social Media)
por: Katsuki, Masahito, et al.
Publicado: (2023)

Fremanezumab for migraine
Publicado: (2020)

Medication Overuse Headache Successfully Treated by Japanese Herbal Kampo Medicine, Yokukansan
por: Katsuki, Masahito, et al.
Publicado: (2021)

Medication Overuse Headache Successfully Treated by Three Types of Japanese Herbal Kampo Medicine
por: Katsuki, Masahito, et al.
Publicado: (2021)

Galcanezumab for migraine
Publicado: (2020)

Musician Conserved Absolute Pitch Ability Despite a Right Parietal Subcortical Hemorrhage
por: Katsuki, Masahito, et al.
Publicado: (2023)

Fremanezumab for migraine prevention: more effective, less costly
Publicado: (2020)

Developing an Artificial Intelligence-Based Pediatric and Adolescent Migraine Diagnostic Model
por: Sasaki, Shiori, et al.
Publicado: (2023)

Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly’s Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City—Itoigawa Hisui Study
por: Katsuki, Masahito, et al.
Publicado: (2022)

Fremanezumab in the treatment of migraines: evidence to date
por: Robblee, Jennifer, et al.
Publicado: (2019)

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days
por: VanderPluym, Juliana, et al.
Publicado: (2018)

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020)

Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
por: Root, Shane, et al.
Publicado: (2023)

Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study
por: Katsuki, Masahito, et al.
Publicado: (2022)

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
por: Friedman, Deborah I., et al.
Publicado: (2020)

Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
por: Martin, Vincent, et al.
Publicado: (2020)

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
por: Raffaelli, Bianca, et al.
Publicado: (2019)

An Evidence-Based Review of Galcanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020)

Photophobia and migraine outcome during treatment with galcanezumab
por: Schiano di Cola, Francesca, et al.
Publicado: (2023)

Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response
por: Pazdera, Ladislav, et al.
Publicado: (2021)

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
por: Detke, Holland C., et al.
Publicado: (2019)

Japanese herbal Kampo medicine, Keishibukuryogan, for chronic subdural hematoma – Prospective observational study
por: Katsuki, Masahito, et al.
Publicado: (2022)

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
por: Lipton, Richard B., et al.
Publicado: (2020)

1.5 Tesla Non-ultrashort but Short Echo Time Magnetic Resonance Angiography Describes the Arteries Near a Clipped Cerebral Aneurysm
por: Higo, Yoichi, et al.
Publicado: (2021)

Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
por: Gklinos, Panagiotis, et al.
Publicado: (2020)

Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
por: Zhao, Xiuyuan, et al.
Publicado: (2020)

Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials
por: Gao, Bixi, et al.
Publicado: (2020)

Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
por: Saigoh, Kazumasa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ukdc8117e3tsb1kv239c5erv3